{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:15Z","timestamp":1740144195003,"version":"3.37.3"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81760086"],"award-info":[{"award-number":["81760086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"crossref","award":["No. 20161BAB215240"],"award-info":[{"award-number":["No. 20161BAB215240"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1097\/md.0000000000022572","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T19:54:21Z","timestamp":1601495661000},"page":"e22572","source":"Crossref","is-referenced-by-count":7,"title":["Atorvastatin associated with gamma glutamyl transpeptidase elevation in a hyperlipidemia patient"],"prefix":"10.1097","volume":"99","author":[{"given":"Yan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"key":"R1-20230103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","article-title":"The pharmacology of statins","volume":"88","author":"Sirtori","year":"2014","journal-title":"Pharmacol Res"},{"key":"R2-20230103","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular out- comes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial","volume":"378","author":"Griffin","year":"2011","journal-title":"Lancet"},{"key":"R3-20230103","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"},{"issue":"(suppl. 3)","key":"R4-20230103","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jacl.2014.02.011","article-title":"An assessment by the Statin Liver Safety Task Force: 2014 update","volume":"8","author":"Bays","year":"2014","journal-title":"J Clin Lipidol"},{"key":"R5-20230103","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mayocpiqo.2019.01.003","article-title":"Risk of statin-induced hypertransaminasemia: a systematic review and meta-analysis of randomized controlled trials","volume":"3","author":"Villani","year":"2019","journal-title":"Mayo Clin Proc Inn Qual Out"},{"key":"R6-20230103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"R7-20230103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R8-20230103","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1345\/aph.1E007","article-title":"Is the Naranjo probability scale accurate enough to ascertain causality in drug-induced hepatotoxicity?","volume":"38","author":"Garc\u00eda-Cort\u00e9s","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R9-20230103","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157488609789006949","article-title":"Adverse effects of statins\u2014mechanisms and consequences","volume":"4","author":"Be1towski","year":"2009","journal-title":"Curr Drug Saf"},{"key":"R10-20230103","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.27157","article-title":"Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network","volume":"60","author":"Russo","year":"2014","journal-title":"Hepatology"},{"key":"R11-20230103","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.20671","article-title":"Statins and hepatotoxicity: focus on patients with fatty liver","volume":"41","author":"Chalasani","year":"2005","journal-title":"Hepatology"},{"key":"R12-20230103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cld.2019.09.007","article-title":"Drug-induced liver injury from statins","volume":"24","author":"Meurer","year":"2020","journal-title":"Clin Liver Dis"},{"key":"R13-20230103","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"Journal of Hepatology"},{"key":"R14-20230103","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1258\/0004563021901685","article-title":"Gamma-glutamyltransferase: value of its measurement in paediatrics","volume":"39","author":"Cabrera-Abreu","year":"2002","journal-title":"Ann Clin Biochem"},{"key":"R15-20230103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1751-7141.2009.00054.x","article-title":"Gamma-glutamyl transferase: a novel cardiovascular risk biomarker","volume":"13","author":"Mason","year":"2010","journal-title":"Prev Cardiol"},{"key":"R16-20230103","first-page":"43","article-title":"Current and emerging biomarkers of hepatotoxicity","author":"Yang","year":"2012","journal-title":"Curr Biomark Find"},{"key":"R17-20230103","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/bjc.2013.323","article-title":"Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer","volume":"109","author":"Grimm","year":"2013","journal-title":"Br J Cancer"},{"key":"R18-20230103","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/156720211798121016","article-title":"Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes","volume":"8","author":"Vandenhaute","year":"2011","journal-title":"Curr Neurovasc Res"},{"key":"R19-20230103","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to antituberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J Clin Exp Hepatol"},{"key":"R20-20230103","first-page":"72","article-title":"An update on treatment of drug induced liver injury","volume":"2","author":"Giordano","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R21-20230103","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00394-017-1407-1","article-title":"Oxidative balance score and serum (-glutamyltransferase level among Korean adults: a nationwide population-based study","volume":"57","author":"Cho","year":"2018","journal-title":"Eur J Nutr"},{"key":"R22-20230103","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12199-019-0828-2","article-title":"Gamma-glutamyl transpeptidase ((-GTP) has an ambivalent association with hypertension and atherosclerosis among elderly Japanese men: a cross-sectional study","volume":"24","author":"Shimizu","year":"2019","journal-title":"Environ Health Prev Med"},{"key":"R23-20230103","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0002-9149(02)02356-1","article-title":"Side effects of statins: hepatitis versus \u201ctransaminitis\u201d: myositis versus \u201cCPKitis\u201d","volume":"89","author":"Dujovne","year":"2002","journal-title":"Am J Cardiol"},{"key":"R24-20230103","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12325-010-0092-8","article-title":"Pitavastatin: a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for the treatment of hyperlipidemia","volume":"28","author":"Baker","year":"2011","journal-title":"Adv Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T20:50:17Z","timestamp":1672779017000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022572"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2020,10,2]]},"references-count":24,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022572","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,10,2]]}}}